Ad is loading...
DEMZX
Price
$21.01
Change
+$0.02 (+0.10%)
Updated
Nov 15 closing price
FNWFX
Price
$80.36
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

DEMZX vs FNWFX

Header iconDEMZX vs FNWFX Comparison
Open Charts DEMZX vs FNWFXBanner chart's image
Delaware Emerging Markets R6
Price$21.01
Change+$0.02 (+0.10%)
VolumeN/A
CapitalizationN/A
American Funds New World F3
Price$80.36
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
DEMZX vs FNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DEMZX vs. FNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DEMZX is a Sell and FNWFX is a Buy.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 60.9B vs. DEMZX (5.25B). DEMZX pays higher dividends than FNWFX: DEMZX (2.84) vs FNWFX (1.56). DEMZX was incepted earlier than FNWFX: DEMZX (9 years) vs FNWFX (8 years). FNWFX is a more actively managed with annual turnover of: 32.00 vs. DEMZX (2.00). DEMZX has a lower initial minimum investment than FNWFX: DEMZX (0) vs FNWFX (1000000). DEMZX annual gain was more profitable for investors over the last year : 14.29 vs. FNWFX (11.59). FNWFX (17.23) and DEMZX (16.54) have equivalent 5 years return.
DEMZXFNWFXDEMZX / FNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years8 years-
Gain YTD7.8547.147110%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.25B60.9B9%
Annual Yield % from dividends2.841.56182%
Returns for 1 year14.2911.59123%
Returns for 3 years-12.20-14.4984%
Returns for 5 years16.5417.2396%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDU55.900.85
+1.54%
New Oriental Education and Technology Group
HTGC18.92-0.13
-0.68%
Hercules Capital
AZ6.49-0.11
-1.67%
A2Z Cust2Mate Solutions Corp
REPL10.80-0.60
-5.26%
Replimune Group
POAI0.69-0.05
-7.23%
Predictive Oncology